Codexis to Present at Two Investment Conferences in March
February 25, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment...
Codexis to Hold 2019 Fourth Quarter and Full Year Conference Call on February 27
February 20, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report 2019 fourth quarter and full year financial...
Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement
January 10, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Jan. 10, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company and developer of novel biotherapeutics, and Nestlé Health Science, a...
Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing
December 23, 2019 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4TM DNA...
Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir
December 05, 2019 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the publication with Merck, known as MSD outside the United...
Codexis Reports Third Quarter 2019 Financial Results
November 05, 2019 16:05 ET
|
Codexis, Inc.
Total revenues rose 29% to $21.9 million driven by strength in R&D, product, and CodeEvolver® licensing revenues Eleven customers each contributed at least a quarter million dollars in revenue ...
Codexis to Participate in Four Investment Conferences in November
November 05, 2019 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in four upcoming investment...
Codexis to Hold Third Quarter 2019 Conference Call on November 5
October 29, 2019 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report third quarter 2019 financial results after...
Codexis’ Protein Engineering Forum Highlights Progress and Future Direction of the Field
October 15, 2019 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, assembled approximately 150 top scientists in protein engineering to...
Codexis to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
September 26, 2019 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at the 2019 Cantor Fitzgerald...